Ocular Therapeutix
OCUL
OCUL
127 hedge funds and large institutions have $214M invested in Ocular Therapeutix in 2023 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
18% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 33
9% more funds holding
Funds holding: 116 → 127 (+11)
0.8% more ownership
Funds ownership: 51.45% → 52.24% (+0.8%)
Holders
127
Holding in Top 10
4
Calls
$4.01M
Puts
$1.94M
Top Buyers
| 1 | +$5.06M | |
| 2 | +$3.97M | |
| 3 | +$2.6M | |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.91M |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$1.5M |
Top Sellers
| 1 | -$4.85M | |
| 2 | -$2.9M | |
| 3 | -$2.22M | |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.91M |
| 5 |
Renaissance Technologies
New York
|
-$1.17M |